TMCnet News

Flex Pharma Appoints Marc Kozin and Stuart Randle to its Board of Directors [Global Data Point]
[October 28, 2014]

Flex Pharma Appoints Marc Kozin and Stuart Randle to its Board of Directors [Global Data Point]


(Global Data Point Via Acquire Media NewsEdge) "With their breadth and depth of experience in healthcare, Marc and Stu will provide a tremendous resource as we endeavor to develop solutions for patients with severe neuromuscular disorders," commented Flex Pharma Co-Founder, Co-Chair of the Company's Scientific Advisory Board and Nobel Laureate, Rod MacKinnon, M.D.



Mr. Kozin brings more than three decades of experience in strategy consulting and deep industry expertise advising biopharmaceutical, life sciences and med-tech companies. He is a Senior Advisor to L.E.K. Consulting, a global strategy consulting firm, and the former President of the North American practice, which he led for 15 years. Mr. Kozin received his M.B.A. from The Wharton School and his B.A. from Duke University.

As a seasoned executive with more than 25 years of experience in the life sciences industry, Mr. Randle most recently served as President and Chief Executive Officer of GI Dynamics from 2004 to 2014. Previously, he served as President and Chief Executive Officer at ACT Medical. Prior to ACT, Mr. Randle was Corporate Officer at Allegiance Healthcare Corporation. He started his career at Baxter Healthcare, where he spent 10 years in various senior management positions. Mr. Randle holds an M.B.A. from The Kellogg Graduate School of Management and a B.S. from Cornell University.


"These appointments further strengthen our Board with expertise across key facets of the healthcare industry. I look forward to working with Marc and Stu and tapping into their industry knowledge," said Flex Pharma Chairman and Chief Executive Officer Christoph Westphal, M.D., Ph.D.

Also on the Board of Directors of Flex Pharma are John Sculley, former Apple CEO and PepsiCo President; Peter Barton Hutt, former General Counsel of the U.S. Food and Drug Administration; Steve Kraus, Partner of Bessemer Venture Partners; and Dr. Westphal, Chairman and Chief Executive Officer of Flex Pharma.

(c) 2014 GlobalData Provided by SyndiGate Media Inc. (Syndigate.info).

[ Back To TMCnet.com's Homepage ]